LTR Pharma Limited
LTPLF
$0.27
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 413.83% | 508.14% | 79.90% | 74.52% | -- |
| Total Receivables | 207.83% | 264.18% | 310.44% | 297.47% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 398.60% | 490.10% | 88.22% | 82.58% | -- |
|
|
|||||
| Total Current Assets | 398.60% | 490.10% | 88.22% | 82.58% | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -81.96% | -78.66% | -- | -- | -- |
| Total Assets | 377.03% | 464.57% | 61.31% | 56.48% | -- |
|
|
|||||
| Total Accounts Payable | 9.42% | 29.50% | 2,056.00% | 1,980.26% | -- |
| Total Accrued Expenses | -9.32% | 7.18% | 1,200.00% | 1,170.15% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 19.89% | 41.83% | 1,927.66% | 1,854.55% | -- |
|
|
|||||
| Total Current Liabilities | 19.89% | 41.83% | 1,927.66% | 1,854.55% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 19.89% | 41.83% | 1,927.66% | 1,854.55% | -- |
|
|
|||||
| Common Stock & APIC | 272.78% | 341.20% | 137.89% | 130.78% | -- |
| Retained Earnings | -113.17% | -152.29% | -276.59% | -265.32% | -- |
| Treasury Stock & Other | 213.26% | 270.73% | 2,356.04% | 2,284.72% | -- |
| Total Common Equity | 395.69% | 486.66% | 42.24% | 37.99% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 395.69% | 486.66% | 42.24% | 37.99% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 395.69% | 486.66% | 42.24% | 37.99% | -- |
|
|
|||||